Ultrasound-guided high-intensity focused ultrasound for symptomatic uterine fibroids: clinical outcome of two European centers
Question To evaluate mid-term clinical efficacy and safety of US-guided high-intensity focused ultrasound (HIFU) for treating symptomatic uterine fibroids and patient outcomes across two European centers. Findings US-guided HIFU treatment resulted in significant fibroid volume reduction (up to 59.1% after 1 year) improving symptoms and quality of life with no major complications. Clinical relevance This prospective longitudinal study provides preliminary data assessing mid-term efficacy and clinical outcomes of ultrasound-guided HIFU. It is shown to be a low-risk, non-invasive treatment option for symptomatic uterine fibroids that reduces fibroid size and improves patients' quality of life.
Authors
- Yoana Ivanova (ORCID: https://orcid.org/0000-0002-2215-9202)
- Dobromir Dimitrov (ORCID: https://orcid.org/0000-0003-3313-1093)
- Olga Ramig
- Eva K. Egger (ORCID: https://orcid.org/0000-0002-9891-3996)
- Markus Essler
- Rupert Conrad (ORCID: https://orcid.org/0000-0003-3207-2677)
- Tolga Tonguc
- Marcus O. Thudium (ORCID: https://orcid.org/0000-0002-9881-4875)
- Holger Strunk (ORCID: https://orcid.org/0000-0003-1839-4063)
- Milka Marinova (ORCID: https://orcid.org/0000-0002-1856-5005)
- Grigor Gortchev (ORCID: https://orcid.org/0000-0002-4710-9340)
- Florian Recker (ORCID: https://orcid.org/0000-0001-9135-4338)
- Sara Dohmen
- Alexander Mustea (ORCID: https://orcid.org/0000-0002-3002-6039)
- Judith M. Stader
Institutions
- University of Bonn (DE)
- University Hospital Bonn (DE)
- University Hospital St. Marina (BG)
- University Hospital Münster (DE)
- Medical University Pleven (BG)
Publication Details
- Journal
- European Radiology
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1007/s00330-024-11230-4
- Citations
- 7
- Primary Topic
- Uterine Myomas and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.08